CN101052419A - 拮抗白介素－21受体活性 - Google Patents

拮抗白介素－21受体活性 Download PDF

Info

Publication number
CN101052419A
CN101052419A CN 200580033595 CN200580033595A CN101052419A CN 101052419 A CN101052419 A CN 101052419A CN 200580033595 CN200580033595 CN 200580033595 CN 200580033595 A CN200580033595 A CN 200580033595A CN 101052419 A CN101052419 A CN 101052419A
Authority
CN
China
Prior art keywords
disease
antibody
antagonist
cell
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200580033595
Other languages
English (en)
Chinese (zh)
Inventor
D·A·杨
M·科林斯
K·杜努西－约安诺普洛斯
R·M·小奥哈拉
M·T·卡塞安
M·J·怀特斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of CN101052419A publication Critical patent/CN101052419A/zh
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN 200580033595 2004-08-05 2005-08-05 拮抗白介素－21受体活性 Pending CN101052419A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59908604P 2004-08-05 2004-08-05
US60/599,086 2004-08-05
US60/639,176 2004-12-23

Publications (1)

Publication Number Publication Date
CN101052419A true CN101052419A (zh) 2007-10-10

Family

ID=38783448

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200580033595 Pending CN101052419A (zh) 2004-08-05 2005-08-05 拮抗白介素－21受体活性

Country Status (2)

Country Link
CN (1) CN101052419A (xx)
ZA (1) ZA200701015B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102105491A (zh) * 2008-05-23 2011-06-22 惠氏有限责任公司 白介素-21受体结合蛋白
CN106794129A (zh) * 2014-04-08 2017-05-31 波士顿制药有限公司 对il‑21具有特异性的结合分子及其用途

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102105491A (zh) * 2008-05-23 2011-06-22 惠氏有限责任公司 白介素-21受体结合蛋白
CN106794129A (zh) * 2014-04-08 2017-05-31 波士顿制药有限公司 对il‑21具有特异性的结合分子及其用途
US10588969B2 (en) 2014-04-08 2020-03-17 Boston Pharmaceuticals, Inc. Antibodies specific for IL-21 and uses thereof
CN106794129B (zh) * 2014-04-08 2020-05-12 波士顿制药有限公司 对il-21具有特异性的结合分子及其用途
US11529415B2 (en) 2014-04-08 2022-12-20 Boston Pharmaceuticals Inc. Antibodies specific for IL-21 and uses thereof

Also Published As

Publication number Publication date
ZA200701015B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
DK1432431T3 (en) Methods and compositions for modulating interleukin-21 activity
KR20070057789A (ko) 인터루킨-21 수용체 활성의 상쇄
US20030108549A1 (en) Methods and compositions for modulating interleukin-21 receptor activity
DK1210425T4 (en) BAFF receptor (BCMA), an immunoregulatory agent
AU776852B2 (en) April receptor (BCMA) and uses thereof
CN1268394C (zh) 结合域－免疫球蛋白融合蛋白
KR20110013391A (ko) Ｃｄ37 면역치료제 및 이작용성 화학치료제와 이의 병용물
CN1878871A (zh) 基于il－1受体的拮抗剂和制造与使用的方法
KR20190126205A (ko) 인터류킨-2 융합 단백질 및 이의 용도
CN1182452A (zh) 促骨生长素
CN1335884A (zh) 类白介素17受体蛋白
CN1774445A (zh) 用于治疗rage相关病症的组合物和方法
CN1940068A (zh) 新的受体核酸及多肽
CN101679497A (zh) 可溶性il-17ra/rc融合蛋白以及相关方法
CN1849131A (zh) 用白介素－21/白介素－21受体的激动剂治疗免疫性疾病
JP2003533488A (ja) 免疫抑制を達成するための組成物および方法
CN109971714A (zh) 自表达pd-1抗体并靶向间皮素的嵌合抗原受体修饰t细胞及其用途
CN101052419A (zh) 拮抗白介素－21受体活性
TWI238191B (en) IL-17 like molecules and uses thereof
CN1649897A (zh) Falp蛋白
CN1845937A (zh) 抗il－20抗体和结合伴侣以及在炎症中的使用方法
CN1878867A (zh) 包含用于治疗自身免疫疾病的基因的重组肽载体
AU2008207646A1 (en) Methods and compositions for modulating interleukin-21 receptor activity
NZ567242A (en) Use of an IL-21/IL-21R agonist for modulating interleukin-21 receptor activity and treating cancer
AU2002330061A1 (en) Methods and compositions for modulating interleukin-21 receptor activity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication